Literature DB >> 5053

Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.

S Berger, E C Ernst, M Barza.   

Abstract

Buffered cephalothin, cefamandole, and cephapirin were compared with respect to their tendency to produce phlebitis. Two grams of each agent was administered every 6 h for 4 days to 12 healthy volunteers in a double-blind crossover fashion. Approximately 50% of intravenous sites developed mild (grade 1) phlebitis and 25% developed moderate (grade 2) phlebitis. The frequency of grade 1 inflammation did not differ significantly among the three cephalosporins. The proportion of individuals eventually exhibiting grade 2 phelebitis was highest with cefamandole, lowest with cephalothin (P = 0.07), and intermediate with cephapirin; however, cephapirin required a substantially greater number of doses to produce grade 2 phelebitis than did the other two drugs. These findings, together with the results of other reports, suggest that interpretation of the phlebitogenic potential of these antibiotics must be made with caution.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5053      PMCID: PMC429579          DOI: 10.1128/AAC.9.4.575

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN.

Authors:  M TURCK; K N ANDERSON; R H SMITH; J F WALLACE; R G PETERSDORF
Journal:  Ann Intern Med       Date:  1965-08       Impact factor: 25.391

2.  Double-blind comparison of phlebitis produced by cefazolin versus cephalothin.

Authors:  N K Shemonsky; J C Carrizosa; D Kaye; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

3.  Effect of buffering on the incidence and severity of cephalothin-induced phlebitis.

Authors:  A G Lipman
Journal:  Am J Hosp Pharm       Date:  1974-03

4.  Phlebitis associated with cephalosporins: cephapirin versus cephalothin.

Authors:  J Inagaki; G P Bodey
Journal:  Curr Ther Res Clin Exp       Date:  1973-02

5.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

6.  Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothin.

Authors:  M G Bergeron; J L Brusch; M Barza; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Double-blind comparison of phlebitis produced by cephalothin infusions with buffered and unbuffered diluents.

Authors:  J Carrizosa; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

8.  Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.

Authors:  J L Bran; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

9.  Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.

Authors:  J Carrizosa; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

10.  Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.

Authors:  A Z Lane; J G Taggart; R L Iles
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

View more
  3 in total

1.  Therapy of serious infections with cefamandole.

Authors:  M F Parry; M J Goldberger; H C Neu
Journal:  Infection       Date:  1978       Impact factor: 3.553

Review 2.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Cefoxitin: clinical evaluation in thirty-eight patients.

Authors:  P N Heseltine; D F Busch; R D Meyer; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.